REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

Clinical trials for REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS trials appear

Sign up with your email to follow new studies for REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New cell therapy tested for severe lupus patients

Disease control Recruiting now

This early-stage study is testing an experimental injection called GC012F in adults with severe systemic lupus erythematosus (lupus) that hasn't improved with standard treatments. The main goals are to check if the treatment is safe and to find the right dose. Researchers will al…

Matched conditions: REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

Phase: PHASE1 • Sponsor: Gracell Biotechnologies (Shanghai) Co., Ltd. • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

Get alerted when new REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS trials appear

New cell therapy tested for severe lupus patients